I am a nuclear medicine physician and Deputy Chief of the Molecular Imaging and Therapy Service. I have a special expertise in oncologic PET/CT for clinical and research purposes, conventional cardiac imaging, cardiac PET and PET/CT, and antibody treatment. I am an active member of several international imaging societies, including the Academy of Molecular Imaging, the Society of Nuclear Medicine, and the Radiological Society of North America, for which I organize and participate in regular Continuing Medical Education lecture series. As a member of the imaging and lymphoma committees of the Cancer and Leukemia Group B, or CALGB, I organize and participate as an expert reader in national, multicenter trials.
My research interests include the following: the assessment of the role of PET/CT imaging in the detection of head and neck cancer and lymphoma and the follow-up of patients with these diseases, the introduction and clinical evaluation of new PET radiotracers in oncology, the role of PET/CT imaging in radiotherapy planning and response assessment, and the development and evaluation of new techniques for motion control in the detection, treatment planning, and response assessment of lung cancer.
I am a member of the disease management teams for head and neck cancer and lymphoma, and I have organized and conducted several multidisciplinary research projects in these areas.